Compare 3M Company (MMM) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
3M Company vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? 3M Company trades at $161.3 (market cap $84.36B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.49 (market cap $25.27B). The key difference: 3M Company is far larger — about 3.3× Royalty Pharma plc Class A Ordinary Shares's market cap, and 3M Company pays the higher dividend (1.91%). Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| MMM | RPRX | |
|---|---|---|
Market Cap | $84.36B | $25.27B |
Volume | 2,325,301 | 3,671,183 |
Sector | Industrials | Health |
52-Week High | $183.79 | $63.96 |
52-Week Low | $141.10 | $35.44 |
Typical Hold Time | 169 Days | 0 Days |
Enterprise Value | $93.58B | $32.50B |
Dividend Yield | 1.91% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
3M (MMM) trades at $162.12, down 0.93% on the day, with a bearish technical signal and support near $158. The company reported strong Q2 2026 earnings, beating estimates with 5.4% organic growth and a 24.9% adjusted operating margin. Revenue for 2025 was $24.95B with net income of $3.25B, though margins have compressed from prior years. Analysts are mixed with a consensus price target of $191, representing potential upside, but high debt and weak consumer sales pose challenges.
The outlook for MMM is cautiously optimistic amid a genuine turnaround narrative. Investment opportunities include continued operational execution, shareholder returns via dividends and buybacks, and growth in industrial and electronics segments. Key risks involve persistent consumer segment weakness, litigation overhang from PFAS, and macroeconomic pressures affecting demand. The stock's valuation remains elevated with a P/E of 29.06, requiring sustained earnings growth to justify further gains.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
